Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia

NCT01757769 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1036

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Silodosin

Sponsor

RECORDATI GROUP